Second Sight Medical Products Revenue and Competitors
Estimated Revenue & Valuation
- Second Sight Medical Products's estimated annual revenue is currently $45.9M per year.
- Second Sight Medical Products received $4.0M in venture funding in October 2018. 0
- Second Sight Medical Products's total funding is $136.8M.
Employee Data
- 00
Second Sight Medical Products's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Financial Reporting | Reveal Email/Phone |
2 | Senior Director, Software Engineering | Reveal Email/Phone |
3 | Director Quality Assurance and Regulatory Affairs | Reveal Email/Phone |
4 | Director, Implant R&D | Reveal Email/Phone |
5 | Director, Clinical and Scientific Affairs | Reveal Email/Phone |
6 | Senior Patent Counsel and Compliance Officer | Reveal Email/Phone |
7 | Director Manufacturing | Reveal Email/Phone |
8 | Senior Vision Rehabilitation Manager | Reveal Email/Phone |
9 | Customer Service Manager | Reveal Email/Phone |
10 | Lead Test Technician Manufacturing | Reveal Email/Phone |
Second Sight Medical Products Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Second Sight Medical Products?
Second Sight's mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight's Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals$136.8M
Total Funding
N/A
Number of Employees
$45.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Second Sight Medical Products News
... ElectroCore LLC, Second Sight Medical Products Inc. This Electroceuticals Market report covers important market segments on the basis of...
... Stimwave LLC, Cefaly Technology, MED-EL, BioElectronics Corporation, ElectroCore LLC, Second Sight Medical Products Inc.
(NASDAQ: EYES) ("Second Sight"), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with...
Second Sight Medical Products Announces Closing of Public Offering Los Angeles, CA - (BUSINESS NEWSWIRE) June 25 , 2021 - Second Sight Medical Products, Inc. (NASDAQ: EYES) ('Second Sight' or the 'Company'), a leading developer of implantable visual prosthetics that are intended to create an ar ...
Second Sight Medical Products Announces Proposed Public Offering of Common Stock Los Angeles, CA - (BUSINESS NEWSWIRE) - June 22, 2021 - Second Sight Medical Products, Inc. (NASDAQ: EYES) ('Second Sight' or the 'Company') a leading developer of implantable visual prosthetics that are intended t ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.2M | 0 | N/A | $3M |
#2 | $45M | 0 | N/A | $476.3M |
#3 | N/A | 0 | N/A | N/A |
#4 | $14M | 0 | N/A | N/A |
#5 | N/A | 0 | N/A | $175.6M |
Second Sight Medical Products Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2014-07-03 | $6.0M | Undisclosed | Article | |
2016-06-02 | $19.4M | Undisclosed | Broadridge Corporate Issuer Solutions, Inc | Article |
2018-05-08 | $10.0M | Undisclosed | Article | |
2018-10-23 | $4.0M | Undisclosed | Article |